The Celebrity Investor
JBL: Big Dreams and Bigger Dollars
01/14/06 - 09:15 AM EST
- Article Tools
- Email this Article
- Print this Article
- Rss Feed
- Related Articles
- Dykstra: Going Deep
- JBL: The Last Drop
- JBL: Fearless Forecasts
- Del.icio.us
- Digg
- StumbleUpon
On a very grass-roots level of due diligence I called my sister, Sylvia Sims, who teaches school in Sweetwater, Texas. She told me the service provided by Educate is invaluable to the education system. This is a boring company. There's nothing fantastic about its numbers; it just continues to grow. I think it is a company you should buy. I do not currently own shares of Educate, but as a guy who speaks and understands Presidential English, I would enjoy owning an education play.
News, News and More News
The State of Maryland just made one of the worst decisions for big business possible. It voted to override the veto of Gov. Robert Ehrlich Jr. on the so-called Wal-Mart (WMT - Cramer's Take - Stockpickr) Bill. The bill states that companies with more than 10,000 employees have to pay 8% of payroll toward health care. This bill is flawed on so many levels, but on the one that affects investors is that it hurts business. I recommended Wal-Mart in mid-October; but, with this ruling and lower-than-expected Christmas sales, the stock is now basically the same price as when I recommended it. I still own my shares of Wal-Mart, and I am not selling them. However, I would not be a buyer here until we see how this plays out nationally. So far it is great news for unions, bad news for business.Everybody Wants a Bad Company
I also recommended Boston Scientific (BSX - Cramer's Take - Stockpickr) in October, and it is now up just slightly due to concerns over a potential bidding war with Johnson & Johnson (JNJ - Cramer's Take - Stockpickr) for Guidant (GDT - Cramer's Take - Stockpickr). J&J first made a bid of $76 per share for Guidant, and then lowered it after a series of recalls of pacemakers and defibrillators. J&J lowered its bid to $63. Boston Scientific jumped in and the bidding has begun for a troubled company. The bids now stand at $73 a share by Boston Scientific and $68 a share by J&J.
01/10/06
Dykstra: Going Deep
A primer on using deep-in-the-money calls, and why to buy Wal-Mart options.
01/07/06
JBL: The Last Drop
The water shortage is big business. Pentair is the best pure play, while Insituform Technologies is well positioned.
01/04/06
JBL: Fearless Forecasts
Prognosticating isn't so hard. The case for equities, Altria, Tsakos and the Longhorns.
08/05/08
Three Internet Stocks That Could Double
These forgotten Internet stocks are being accumulated by hedge funds.
08/15/08
The Five Dumbest Things on Wall Street
Raspberries for Apple; You'll be sorry, UBS; Fortress or Fort Knox? Wholly unappetizing Foods; give Liberty AOL or give them...
08/15/08
McCain Fund-Raising Picks Up
The GOP presidential candidate raised $27 million in July.
08/15/08
Cash-Back Cards Aren't Money in the Bank
Some credit and debit cards give you some cash back on purchases. But you need to manage it well to benefit from it.
More popular tickers are indicated by scale.
Sponsored by:
RSS
